Complex lipid trafficking in Niemann-Pick disease type C

被引:197
|
作者
Vanier, Marie T. [1 ]
机构
[1] Univ Lyon 1, EA4611, INSERM, Fac Med Lyon Est,U820, F-69008 Lyon, France
关键词
LYSOSOMAL STORAGE DISORDER; LOW-DENSITY-LIPOPROTEIN; CHOLESTEROL ACCUMULATION; ACID SPHINGOMYELINASE; ENDOSOMAL CHOLESTEROL; NPC1; DEFICIENCY; UNESTERIFIED CHOLESTEROL; IMPAIRED AUTOPHAGY; PROTEIN; METABOLISM;
D O I
10.1007/s10545-014-9794-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Niemann-Pick disease type C (NPC) is an atypical lysosomal storage disease resulting from mutations in one of two genes, either NPC1 or NPC2. Although a neurovisceral disorder, it is above all a neurodegenerative disease in the vast majority of patients. Not an enzyme deficiency, it is currently conceived as a lipid trafficking disorder. Impaired egress of cholesterol from the late endosomal/lysosomal (LE/L) compartment is a specific and key element of the pathogenesis, but other lipids, more specially sphingolipids, are also involved, and there are indications for further abnormalities. The full function of the NPC1 and NPC2 proteins is still unclear. This review provides a reappraisal of lipid storage and lysosomal enzymes activities in tissues/cells from NPC patients and animal models. It summarizes the current knowledge on the NPC1 and NPC2 proteins and their function in transport of cholesterol within the late endosomal-lysosomal compartment, with emphasis on differences between systemic organs and the brain; it also discusses regulation by membrane lipids of the NPC2-mediated cholesterol trafficking, interplay between cholesterol and sphingomyelin, the metabolic origin of glycosphingolipids stored in brain, and the putative role of free sphingoid bases in pathogenesis. Brief mention is finally made of diseases affecting other genes that were very recently shown to impact the "NPC pathway".
引用
收藏
页码:187 / 199
页数:13
相关论文
共 50 条
  • [1] Niemann-Pick type C disease and intracellular cholesterol trafficking
    Chang, TY
    Reid, PC
    Sugii, S
    Ohgami, N
    Cruz, JC
    Chang, CCY
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (22) : 20917 - 20920
  • [2] Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C
    Lachmann, RH
    Vruchte, DT
    Lloyd-Evans, E
    Reinkensmeier, G
    Sillence, DJ
    Fernandez-Guillen, L
    Dwek, RA
    Butters, TD
    Cox, TM
    Platt, FM
    NEUROBIOLOGY OF DISEASE, 2004, 16 (03) : 654 - 658
  • [3] Niemann-Pick disease type C
    Vanier, M
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1996, 27 (01) : 70 - 72
  • [4] Niemann-Pick disease type C
    Liscum, L
    Klansek, JJ
    CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (02) : 131 - 135
  • [5] Type C Niemann-Pick disease
    Cobcroft, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (03) : 718 - 718
  • [6] Niemann-Pick type C disease
    Sheth, Jayesh J.
    Sheth, Frenny J.
    Oza, Nrupesh
    INDIAN PEDIATRICS, 2008, 45 (06) : 505 - 507
  • [7] Niemann-Pick disease type C
    Vanier, MT
    Millat, G
    CLINICAL GENETICS, 2003, 64 (04) : 269 - 281
  • [8] Niemann-Pick disease type C
    Marie T Vanier
    Orphanet Journal of Rare Diseases, 5
  • [9] Niemann-Pick disease type C
    Vanier, Marie T.
    ORPHANET JOURNAL OF RARE DISEASES, 2010, 5
  • [10] Niemann-Pick type C: A disorder of cellular cholesterol trafficking
    Ory, DS
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1529 (1-3): : 331 - 339